3Wei-Min Wang,Yang Xu,Xin-Rong Yang,Yao-Hui Wang,Hai-Xiang Sun and Jia Fan Institute of Biomedical Sciences,Fudan University,Shanghai 200032,China ,Key Laboratory of Carcinogenesis and Cancer Invasion,Ministry of Education,and Liver Cancer Institute,Zhongshan Hospital,Fudan University,Shanghai 200032,China ,Fudan University Shanghai Cancer Center,Shanghai 200032,China.Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments:a meta-analysis[J].Hepatobiliary & Pancreatic Diseases International,2011,10(4):346-355. 被引量：10
4Gennafi R,Curigliano G, Rotmensz N,et al. Breast carcinoma in elderlywomen : features of disease presentation, choice of local and systemictreatments compared with younger postmenopasual patients [J]. Cancer,2004,101 (6) :1302. 被引量：1
5Muss HB. Adjuvant therapy for ohterbreast cancer patients[J]. Breast, 2003,12 ( 6 ) :550. 被引量：1
6Pierga JY, Girre V, Laurence V, et al. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age[J]. Breast,2004,13 ( 5 ) : 369. 被引量：1
7De Michele A,Putt M,Zhang Y,et al. Older age predicts a decline in adjuvant chemotherapy recommendation for patients with breast carcinoma evidence from a tertiary care cohort of chemotherapy eligible patients [J]. Cancer, 2003,97(9):2150. 被引量：1
8Singh R, Hellman S, Heimann R. The natural historu, of breast carcinoma in the elderly: implication for screening and treatment[J]. Cancer, 2004,100(9 ) :1807. 被引量：1
9Hughes KS, Sehnaper LA, Berry. D, et at. Lumpeetomy plus tamoxifen with or without irradiation in women to years of age or older wilh early breast cancer [J]. N Engl J Med,2004,351 (10) :971. 被引量：1
10Oderdoal Jde V, Apffelstaedt JP. Limited surger? and tamoxifen in the treatment of elderly breast cancer patients [J]. Word J Surg, 2003,27 (2) :125. 被引量：1
4Ogunleye AA, Ogston SA, Evans JM, et al. A cohort study of the risk of cancer associated with type 2 diatebets[J]. Br J Cancer, 2009,101 (7) : 1199-1201. 被引量：1
5Curri'e C J, Poole CD, Evans M, et al. Mortality and other impor- tant diabetes-related outcomes with insulin vs other antihyper- glyeemic therapies in type 2 diabetes[J]. J Clin Endocrinol Metab, 2013,98 (2):668-677. 被引量：1
6Colmers IN, Bowker SL,Tjosvold LA, et ah Insulin use and can- cer risk in patients with type 2 diabetes : a systematic review and meta-analysis of observational studies[J]. Diabetes Metab, 2012, 38(6) :485-506. 被引量：1
7Giovannueei E, Harlan DM,Archer MC, et al. Diabetes and can- cer: a consensus report[J]. CA Cancer J Clin, 2010,60 (4) : 207-221. 被引量：1
8Kalli KR, Falowo OI, Bale LK, et al. Functional insulin receptors on human epithelial ovarian carcinoma cells :implications for IGF- Ⅱ mitogenic signaling[J]. Endocrinology,2002,143 (9) : 3259-3267. 被引量：1
9Guastamacchia E, Resta F, Triggiani V, et al. Evidence for a pu- tative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer:role of hormones ,growth factors and specific receptors[J]. Curr Drug Targets Immune En- docr Metabol Disord ,2004,4( 1 ) :59-66. 被引量：1
10Wu Y, Yakar S, Zhao L, et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis [J]. Cancer Res,2002,62(4) : 1030-1035. 被引量：1
